Abstract
Cardiogenic shock remains the most common cause of death in patients with acute myocardial infarction. Early revascularization of the infarct-related artery has been shown to reduce mortality and is the therapeutic cornerstone. The optimal revascularization strategy of additional non-culprit lesions remains yet to be determined. Further, uncertainties exist with respect to access site choice, antiplatelet regimen as well as mechanical support devices. This review outlines current evidence on the interventional management of cardiogenic shock complicating acute myocardial infarction.
| Translated title of the contribution | Interventional therapies in acute myocardial infarction complicated by cardiogenic shock |
|---|---|
| Original language | German |
| Journal | Herz |
| Volume | 42 |
| Issue number | 1 |
| Pages (from-to) | 11-17 |
| Number of pages | 7 |
| ISSN | 0340-9937 |
| DOIs | |
| Publication status | Published - 01.02.2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Interventional therapies in acute myocardial infarction complicated by cardiogenic shock'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver